JenaValve Raises $62.5 Million To Fund Transfemoral TAVI Trial And More
Funds will help the German company continue developing its JenaValve transcatheter aortic valve, including a new clinical trial of the transfemoral version of the system.
Funds will help the German company continue developing its JenaValve transcatheter aortic valve, including a new clinical trial of the transfemoral version of the system.